Logo image of ASPA

ABRI SPAC I INC (ASPA) Stock Fundamental Analysis

NASDAQ:ASPA - Nasdaq - US00085X1054 - Common Stock - Currency: USD

27.05  +14.45 (+114.68%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ASPA. ASPA was compared to 0 industry peers in the Unkown industry. ASPA may be in some trouble as it scores bad on both profitability and health. ASPA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ASPA has reported negative net income.
In the past year ASPA has reported a negative cash flow from operations.
ASPA Yearly Net Income VS EBIT VS OCF VS FCFASPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -11.75%
ROE -26.52%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPA Yearly ROA, ROE, ROICASPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -10 -20 -30

1.3 Margins

ASPA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASPA Yearly Profit, Operating, Gross MarginsASPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ASPA has less shares outstanding
The debt/assets ratio for ASPA is higher compared to a year ago.
ASPA Yearly Shares OutstandingASPA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2M 4M 6M
ASPA Yearly Total Debt VS Total AssetsASPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

ASPA has an Altman-Z score of 3.46. This indicates that ASPA is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.52 indicates that ASPA is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 3.46
ROIC/WACCN/A
WACCN/A
ASPA Yearly LT Debt VS Equity VS FCFASPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 0.09 indicates that ASPA may have some problems paying its short term obligations.
A Quick Ratio of 0.09 indicates that ASPA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
ASPA Yearly Current Assets VS Current LiabilitesASPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

ASPA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.50%.
EPS 1Y (TTM)-24.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASPA Yearly Revenue VS EstimatesASPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
ASPA Yearly EPS VS EstimatesASPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASPA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPA Price Earnings VS Forward Price EarningsASPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASPA Per share dataASPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASPA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABRI SPAC I INC

NASDAQ:ASPA (10/25/2023, 8:00:00 PM)

27.05

+14.45 (+114.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)11-14 2023-11-14
Inst Owners6.22%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap65.19M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.58
P/tB 10.58
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS2.56
TBVpS2.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.75%
ROE -26.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 3.46
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.75%
OCF growth 3YN/A
OCF growth 5YN/A